Publication | Closed Access
OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
15
Citations
0
References
2013
Year
No additional data available for this publication yet. Check back later!